09 Nov Collagen Triple Helix Repeat Containing 1 (CTHRC1) is a prostate cancer prognosis biomarker regulated by androgen receptor activity
Posted at 01:02h
in New frontiers in treatment/Precision medicine
ID: 2402
Autores: Paulano, Alvaro (0); Gonzalo, Alvaro (1); Macchia, Alice (1,2); Armendariz, Uxue (1); Lopez, Jose Ignacio (5); Garcia, Saioa (2); Valcarcel, Lorea (1); Carracedo, Arkaitz (2,3,4); Torrano, Verónica (1,3)
Temática: New frontiers in treatment/Precision medicine
Leer completo